Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery
NCT ID: NCT05871073
Last Updated: 2023-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2023-01-01
2023-03-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: In this study, we randomly assigned sixty patients undergoing lumbar laminectomy and/or osteosynthesis into two groups of 30 patients each. The control group (R-group) received only Ropivacaine (150 mg of Ropivacaine 7.5% (20 ml) added to 2 ml of normal saline in the wound infiltration), while the intervention group (RD-group) received Ropivacaine with the addition of dexamethasone (150 mg of Ropivacaine 7.5% (20 ml) added to 8 mg of dexamethasone in the wound infiltration). Both groups were administered patient-controlled analgesia (PCA) with morphine for self-medication.
Postoperatively, a blinded evaluator assessed pain at H0, recorded the assessment of surgical scar pain using the Visual Analog Scale (VAS) at 4, 6, 12, 24, and 48 hours, as well as the time to the first opioid request, cumulative morphine consumption, opioid-related side effects, and length of stay. All patients were scheduled for a 3-month follow-up call to monitor chronic pain progression.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Perineural Dexamethasone Versus Dexmedetomidine as Adjuvants to Erector Spinae Plane Block in Lumbar Spine Surgery: A Randomized, Double-blind, Controlled Trial
NCT07180940
Dexamethasone Plus Bupivacaine Versus Bupivacaine in Bilateral Trans-incisional Paravertebral Block in Lumbar Spine Surgeries .
NCT04783194
Intravenous Dexamethasone for Prolonging Sensory Block in Spinal Anesthesia
NCT07088432
Role of Dexamethasone for Erector Spinae Plane Block in Patients Undergoing Total Abdominal Hysterectomy
NCT03769818
Impact of Dexamethasone on the Duration of Sensory and Motor Block Following Spinal Anesthesia
NCT03078062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ropivacaine 0.75% Injectable Solution
Wound Infiltration for Postoperative Analgesia After Spinal Surgery
Ropivacaine 0.75% Injectable Solution
WOUND INFILTRATION AFTER SPINAL SURGERY
Dexamethasone 8mg
Wound Infiltration for Postoperative Analgesia After Spinal Surgery
Ropivacaine 0.75% Injectable Solution
WOUND INFILTRATION AFTER SPINAL SURGERY
dexamethasone 8mg
WOUND INFILTRATION AFTER SPINAL SURGERY
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine 0.75% Injectable Solution
WOUND INFILTRATION AFTER SPINAL SURGERY
dexamethasone 8mg
WOUND INFILTRATION AFTER SPINAL SURGERY
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Fattouma Bourguiba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Atef Ben Nsir
UNIVERSITY OF MONAASTIR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ATEF BEN NSIR, PHD
Role: STUDY_CHAIR
HOPITAL UNIVERSITAIRE FATTOUMA BOURGUIBA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Fattouma Burguiba Monastir
Monastir, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PAIN MANAGMENT IN SURGERY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.